Studies have shown that melanoma patients with high expression of GBP family, including GBP1, have a good prognosis in the 30-year follow-uperiod, which is consistent with the result in this study that the decline in GBP1 expression predicts poor prognosis of patients (44). Here, GBP1 is linked to melanoma.